生殖道沙眼衣原体感染的疾病负担研究进展

doi:10.12183/j.scjpm.2023.1075

摘要/Abstract

摘要： 生殖道沙眼衣原体感染是最常见的性传播感染之一,主要引起人体的生殖道感染,其导致的症状和远期不良后果可引起患者生殖健康损害,造成经济损失,影响人口发展。本研究旨在对国内外生殖道沙眼衣原体感染疾病负担进行综述,总结研究进展,为生殖道沙眼衣原体防控提供参考。

关键词: 沙眼衣原体, 疾病负担, 经济负担, 伤残调整寿命年

中图分类号:

R183

王劲燊, 徐文倩, 赵培祯, 王成. 生殖道沙眼衣原体感染的疾病负担研究进展[J]. 华南预防医学, 2023, 49(9): 1075-1077.

[1] Unemo M,Bradshaw CS,Hocking JS,et al.Sexually transmitted infections: Challenges ahead[J].Lancet Infect Dis,2017,17(8):e235-e279.
[2] 中国疾病预防控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会.梅毒,淋病和生殖道沙眼衣原体感染诊疗指南(2020年)[J].中华皮肤科杂志,2020,53(3):168-179.
[3] Dombrowski JC.Chlamydia and gonorrhea[J].Ann Intern Med,2021,174(10): 145-160.
[4] Tang W, Mao J, Li KT, et al.Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: A global systematic review and meta-analysis[J]. Sex Transm Infect,2020,96(5):322-329.
[5] Bhuvanendran Pillai A, Mun Wong C, Dalila Inche Zainal Abidin N, et al. Chlamydia infection as a risk factor for cervical cancer: A systematic review and meta-analysis[J]. Iran J Public Health,2022,51(3):508-517.
[6] Dzakah EE, Zhao J, Wang L, et al.Chlamydia trachomatis stimulation enhances HIV-1 susceptibility through the modulation of a member of the macrophage inflammatory proteins[J].J Invest Dermatol,2022,142(5):1338-1348.
[7] 马婉婉,朱玉良,苏斌,等.传染病类疾病负担评价方法研究进展[J].安徽预防医学杂志, 2019,25(5):374-377,385.
[8] Yoon SJ, Go DS, Park H, et al.The Korean national burden of disease study: From evidence to policy[J]. J Korean Med Sci,2019,34(Suppl 1):e89.
[9] World Health Organization.Global progress report on HIV, viral hepatitis and sexually transmitted infections,2021: Accountability for the global health sector strategies 2016-2021: Actions for impact:Web annex 2: Data methods[M].Geneva:World Health Organization, 2021:8.
[10] Low N, Hocking JS, Van Bergen J.The changing landscape of chlamydia control strategies[J].Lancet,2021,398(10309):1386-1388.
[11] Kirby Institute.HIV, viral hepatitis and sexually transmissible infections in Australia:Annual surveillance report 2022[M].Sydney:Kirby Institute,UNSW,2022:5.
[12] Public Health Agency of Canada. Chlamydia,gonorrhea and infectious syphilis in Canada,2019(infographic)[EB/OL].(2022-02-14)[2022-09-12].https://www.canada.ca/en/public-health/services/publications/diseases-conditions/chlamydia-gonorrhea-infectious-syphili-canada-2019.html.
[13] 岳晓丽,龚向东,李婧,等.2015—2019年中国性病监测点生殖道沙眼衣原体感染流行病学特征[J].中华皮肤科杂志,2020,53(8):596-601.
[14] Huai P, Li F, Li Z, et al.Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province,China: A population-based,cross-sectional study[J].BMC Infect Dis,2018,18(1):534.
[15] Li C, Tang W, Ho HC, et al. Prevalence of chlamydia trachomatis among pregnant women, gynecology clinic attendees,subfertile women in Guangdong, China:A cross-sectional survey[J].Open Forum Infect Dis,2021,8(6):ofab206.
[16] Gerbase A, Stein C, Levison J, et al.Global burden of sexually transmitted diseases (excluding HIV) in the year 2000[M].Geneva:World Health Organization,2000:5.
[17] Davies B, Turner KME, Frolund M, et al.Risk of reproductive complications following chlamydia testing:A population-based retrospective cohort study in Denmark[J].Lancet Infect Dis,2016,16(9):1057-1064.
[18] Den Heijer CDJ, Hoebe CJPA, Driessen JHM, et al.Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility:A retrospective cohort study among primary care patients[J]. Clin Infect Dis,2019,69(9):1517-1525.
[19] Ahmadi A, Ramazanzadeh R, Sayehmiri K, et al.Association of Chlamydia trachomatis infections with preterm delivery: A systematic review and meta-analysis[J].BMC Pregnancy Childbirth,2018,18(1):240.
[20] Rand LZ, Kesselheim AS.Controversy over using quality-adjusted life-years in cost-effectiveness analyses:A systematic literature review[J].Health Aff (Millwood), 2021, 40(9):1402-1410.
[21] Li Y, You S, Lee K, et al.The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018[J].J Infect Dis, 2023, 227(8):1007-1018.
[22] 李茜瑶,周莹,黄辉,等.疾病负担研究进展[J].中国公共卫生,2018,34(5): 777-780.
[23] 雷少元,郑荣寿,魏文强.伤残权重在恶性肿瘤疾病负担研究中的进展[J].中华肿瘤杂志,2021,43(7):756-761.
[24] Zheng Y, Yu Q, Lin Y, et al.Global burden and trends of sexually transmitted infections from 1990 to 2019:An observational trend study[J]. Lancet Infect Dis,2022,22(4):541-551.
[25] van Lier A, Mcdonald SA, Bouwknegt M, et al. Disease burden of 32 infectious diseases in the Netherlands,2007-2011[J].PLoS One,2016,11(4):e0153106.
[26] Sabbatucci M, Salfa MC, Regine V, et al.Estimated burden of chlamydia trachomatis female infection and consequent severe pelvic inflammatory disease, Italy,2005-2016[J].Ann Ist Super Sanita,2019,55(3):217-223.
[27] 杨晓雨,陈东宇,王红心,等.中国5种性传播感染的流行趋势[J].中国循证医学杂志, 2022, 22(7):778-784.
[28] 陈颖,龚巍巍.脑卒中经济负担研究方法及应用进展[J].预防医学,2019,31(6): 578-581,585.
[29] Owusu-Edusei K, Chesson HW, Gift TL, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States,2008[J].Sex Transm Dis,2013,40(3): 197-201.
[30] Chesson HW, Spicknall IH, Bingham A, et al.The estimated direct lifetime medical costs of sexually transmitted infections acquired in the United States in 2018[J].Sex Transm Dis,2021,48(4):215-221.
[31] Zou Y, Liao Y, Liu F, et al.The annual economic burden of syphilis:An estimation of direct,productivity,and intangible costs for syphilis in Guangdong initiative for comprehensive control of syphilis sites[J].Sex Transm Dis,2017,44(11): 671-677.
[32] Kumar S, Chesson H, Gift TL.Estimating the direct medical costs and productivity loss of outpatient chlamydia and gonorrhea treatment[J].Sex Transm Dis,2021,48(2):e18-e21.
[33] Lee ASD, Cody SL.The stigma of sexually transmitted infections[J].Nurs Clin North Am,2020,55(3):295-305.
[34] Shui J, Xie D, Zhao J, et al.Seroepidemiology of chlamydia trachomatis Infection in the general population of Northern China: The Jidong Community Cohort Study[J].Front Microbiol,2021,12:729016.
[35] 胡跃华,李镒冲,刘世炜,等.中国20年间淋球菌,性传播衣原体,梅毒螺旋体的发病情况及其疾病负担[J].疾病监测,2015,30(11):904-910.
[36] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019BD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222.
[37] 中国疾病预防控制中心性病控制中心.关于印发《2022年全国性病防治工作要点》的通知[EB/OL].(2022-02-22)[2022-12-23].https://www.ncstdc.cn/#/home/ArticleDetails/u%3A6214481171f0a02a446b2441%23@a%3AXieshoue_Spread%23/STD_Official_Web_Home_Notice.

生殖道沙眼衣原体感染的疾病负担研究进展

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	李伟伟, 董建梅, 秦绪成, 马昭君, 韩仁强, 俞浩. 1990—2019年江苏省甲状腺癌疾病负担及时间趋势分析[J]. 华南预防医学, 2023, 49(7): 808-812.
[2]	郭珈汛, 宋佳烨, 季从飞, 肖金章. 2010—2021年南通地区女性乳腺癌疾病负担研究[J]. 华南预防医学, 2023, 49(7): 904-907.
[3]	李静华, 徐浩锋, 秦发举, 孟瑞琳, 许滢珊, 张雪亮, 周志珊, 朱旭豪, 彭丹丹, 李川. 2005—2015年广东省户籍居民交通伤害疾病负担变化趋势[J]. 华南预防医学, 2023, 49(5): 548-552.
[4]	李艳妮, 朱晴, 孙欢, 张花, 施艳, 彭阿丽, 王素娜. 西安地区脑卒中患者直接经济负担及影响因素分析[J]. 华南预防医学, 2023, 49(3): 315-320.
[5]	郑雪燕, 许燕君, 马书丽, 曾新颖, 许晓君, 孟瑞琳, 林立丰. 广东省2005年与2015年健康期望寿命研究[J]. 华南预防医学, 2023, 49(2): 150-155.
[6]	范双华, 虞云娟, 彭秀华, 秦晶, 陈迪, 吴建军. 2019—2021年溧阳地区医疗机构消化系统疾病就诊者疾病谱变化及病例特征分析[J]. 华南预防医学, 2023, 49(10): 1285-1289.
[7]	蔡会龙, 刘淳, 原伟光, 郭晶杰, 林晶, 孙惠昕. 1990年与2019年中国归因于低体力活动的疾病负担分析[J]. 华南预防医学, 2023, 49(10): 1294-1297.
[8]	王红心, 樊文龙, 杨晓雨, 陈东宇, 黄巧, 潘素跃, 王朴, 胡敏, 何玉清. 亚洲五个国家和地区肾癌负担趋势分析与预测[J]. 华南预防医学, 2023, 49(1): 1-4.
[9]	吴英祥, 林立丰, 郑雪燕, 廖婷婷, 孟瑞琳, 许晓君, 许燕君. 2005—2015年广东省消化系统疾病负担变化趋势分析[J]. 华南预防医学, 2022, 48(9): 1095-1098.
[10]	梁大艳, 孟瑞琳, 李川, 许晓君, 郑雪燕, 许滢珊, 彭丹丹, 宋秀玲. 2005—2015年广东省老年人帕金森病死亡率和伤残调整寿命年及变化趋势[J]. 华南预防医学, 2022, 48(9): 1099-1102.
[11]	梁大艳, 孟瑞琳, 李川, 许晓君, 郑雪燕, 许滢珊, 彭丹丹, 宋秀玲. 2005—2015年广东省老年人阿尔茨海默病及其他痴呆死亡率和伤残调整寿命年及变化趋势[J]. 华南预防医学, 2022, 48(8): 963-967.
[12]	张佛金, 林立丰, 许燕君, 许晓君, 王晔, 李爱娟, 古彩红, 孟瑞琳. 2005—2015年广东省传染性疾病的疾病负担分析[J]. 华南预防医学, 2022, 48(8): 959-962.
[13]	吴晓惠, 林立丰, 孟瑞琳, 许燕君, 许晓君, 郑雪燕, 王晔, 周兵, 张美娜, 周少恩, 马书丽. 2005—2015年广东省慢性肾脏病疾病负担研究[J]. 华南预防医学, 2022, 48(8): 956-958.
[14]	樊文龙, 王红心, 陈东宇, 杨晓雨, 何玉清. 1990—2019年亚洲地区接触性皮炎疾病负担研究[J]. 华南预防医学, 2022, 48(7): 786-791.
[15]	朱晖, 李聪, 田艳玲, 李亚飞. 郑州市金水区老年人群心血管病流行情况及影响因素分析[J]. 华南预防医学, 2022, 48(5): 547-550.